Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.

By C. Fichtenberg, S. Glantz. 2000

340 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, Physiology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Alberto Abadie
2. A. Diamond
3. Jens Hainmueller

In Pathology and Forensic Medicine

1. Alberto Abadie
2. A. Diamond
3. Jens Hainmueller

In Physiology

1. Alberto Abadie
2. A. Diamond
3. Jens Hainmueller

Citations in the corpus

• Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California’s Tobacco Control Program (2010, methodology): “While we eliminate these states as potential controls, Fichtenberg and Glantz (2000) do not do so, which is likely to attenuate their estimates.”
• Effectiveness of tax and price policies in tobacco control (2010, background): “The reductions in tobacco use that result from higher taxes and prices lead to reductions in the death and disease caused by tobacco use”
• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, neutral): “Some authors credit the greater use of evidence-based medical therapies such as thrombolysis, aspirin, angiotensin-converting enzyme (ACE) inhibitors, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) surgery,(26,27) while others credit improved management of major ri”